IP Library › Granted Patent US 10,195,283
Granted Patent B2
US 10,195,283 · App. 15/459,887 · Granted Feb 5, 2019

Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate

Inventors: Stepan Chuprakov (Emeryville, CA); Romas Alvydas Kudirka (El Cerrito, CA); Jesse M. McFarland (Berkeley, CA); Albert W. Garafalo (South San Francisco, CA); David Rabuka (Kensington, CA)
Assignee: R.P. Scherer Technologies, LLC
A61K47/48061A61K47/48384C07D498/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,195,283
App. No.
15/459,887
Granted
Feb 5, 2019
Kind
B2
Abstract

The present disclosure provides conjugate structures and hydrazinyl-substituted heteroaryl compounds used to produce these conjugates. The disclosure also encompasses methods of production of such conjugates and compounds, as well as methods of using the same.

Claims (573)

1. A conjugate comprising at least one modified amino acid residue of formula (I):

wherein:

R 1 and R 2 are each independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

one of R 3 and R 4 is a polypeptide and the other is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

R 5 and R 6 are each independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or R 5 and R 6 are cyclically linked to form a 5 or 6-membered heterocyclyl;

Z 1 is selected from CR 7 , N, O and S;

Z 2 is C or N;

R 7 is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

L is a linker; and

W is a drug or a detectable label.

2. The conjugate of claim 1 , wherein Z 1 and Z 2 are each N.

3. The conjugate of claim 1 , wherein Z 1 is CR 7 and Z 2 is N.

4. The conjugate of claim 1 , wherein Z 1 is O and Z 2 is C.

5. The conjugate of claim 1 , wherein R 3 is the polypeptide.

6. The conjugate of claim 1 , wherein R 4 is the polypeptide.

7. The conjugate of claim 1 , wherein R 5 and R 6 are each independently selected from alkyl and substituted alkyl.

8. The conjugate of claim 1 , wherein R 7 is hydrogen.

9. The conjugate of claim 1 , wherein:

the linker is of the formula -(T 1 -V 1 ) a -(T 2 -V 2 ) b -(T 3 -V 3 ) c -(T 4 -V 4 ) d -(T 5 -V 5 ) e —, wherein a, b, c, d and e are each independently 0 or 1, where the sum of a, b, c, d and e is 1 to 5;

T 1 , T 2 , T 3 , T 4 and T 5 are each independently selected from (C 1 -C 12 )alkyl, substituted (C 1 -C 12 )alkyl, (EDA) w , (PEG), (AA) p , —(CR 13 OH) h —, 4-amino-piperidinyl (4AP), para-aminobenzyl (PAB), para-amino-benzyloxy (PABO), meta-amino-benzyloxy (MABO), para-amino-benzyloxycarbonyl (PABC), meta-amino-benzyloxycarbonyl (MABC), an acetal group, a disulfide, a hydrazine, a carbohydrate, a beta-lactam, an ester, (AA) p -MABO, (AA) p -MABC, (AA) p -PABO, (AA) p -PABC, MABO-(AA) p , MABC-(AA) p , PABO-(AA) p , PABC-(AA) p , (AA) p -MABO-(AA) p , (AA) p -MABC-(AA) p , (AA) p -PABO-(AA) p , and (AA) p -PABC-(AA) p ;

V 1 , V 2 , V 3 , V 4 and V 5 are each independently selected from the group consisting of a covalent bond, —CO—, —NR 11 —, —CONR 11 —, —NR 11 CO—, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO 2 —, —SO 2 NR 11 —, —NR 11 SO 2 — and —P(O)OH—;

each R 11 and R 13 is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;

w is an integer from 1 to 20;

n is an integer from 1 to 30;

p is an integer from 1 to 20; and

h is an integer from 1 to 12.

10. The conjugate of claim 9 , wherein:

EDA is an ethylene diamine having the structure:

 wherein q is an integer from 1 to 6, r is 0 or 1, and each R 12 is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or wherein two adjacent R 12 groups are cyclically linked to form a piperazinyl ring;

PEG is a polyethylene glycol or a substituted polyethylene glycol;

AA is an amino acid residue; and

4AP is

 wherein each R 14 is independently selected from hydrogen, alkyl, substituted alkyl, polyethylene glycol, substituted polyethylene glycol, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

11. The conjugate of claim 10 , wherein each R 11 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

12. The conjugate of claim 10 , wherein each R 12 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or wherein two adjacent R 12 groups are cyclically linked to form a piperazinyl ring.

13. The conjugate of claim 10 , wherein each R 13 is independently selected from hydrogen, alkyl, substituted alkyl, aryl, and substituted aryl.

14. The conjugate of claim 10 , wherein each R 14 is independently selected from hydrogen, alkyl, substituted alkyl, polyethylene glycol, substituted polyethylene glycol, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

15. The conjugate of claim 10 , wherein T 1 , T 2 , T 3 , T 4 and T 5 and V 1 , V 2 , V 3 , V 4 and V 5 are selected from the following table:

T 1

V 1

T 2

V 2

T 3

V 3

T 4

V 4

T 5

V 5

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(C 1 -C 12 )alkyl

—CO—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—NR 11 —

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—NR 11 —

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(EDA) w

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CO—

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—SO 2 —

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(CR 13 OH) h

—CO—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(PEG) n

—CO—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

substituted

—NR 11 —

(PEG) n

—CO—

—

—

—

—

(C 1 -C 12 )alkyl

(C 1 -C 12 )alkyl

—SO2—

(C 1 C 12 )alkyl

—CO—

—

—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—

(CR 13 OH) h

—CONR 11 —

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—NR 11 —

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—P(O)OH—

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(AA) p

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

—

—CO—

—

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(C 1 -C 12 )alkyl

—NR 11 —

—

—CO—

(C1-C1 2 )alkyl

—NR 11 —

—

—

(C 1 -C 12 )alkyl

—CO—

(EDA) w

—CO—

(CR 13 OH) h

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

MABO

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

MABC

—

(AA) p

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p -

—NR 11 —

(C 1 -C 12 )alkyl

—CO—

PABC

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—

PABC

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—

PABO

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p -

—

—

—

PABC-(AA) p

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

(AA) p

—

PABC-(AA) p

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

PABO

—

—

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

PABO

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

MABO

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

PABC

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

MABC

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

PABC

—

(AA) p

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

MABO

—

—

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

PABO

—

—

—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—NR 11 —

(PEG) n

—CO—

PABC

—

—

—

(C 1 -C 12 )alkyl

—CONR 11 —

(PEG) n

—CO—

MABC

—

(AA) p

—

—

—

(C 1 -C 12 ))alkyl

—CONR 11 —

(PEG) n

—CO—

(AA) p

—

PABC

—NR 11 —

—

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

PABC

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA)p

—

PABC-(AA) p

—

(C 1 -C 12 )alkyl

—CO—

4AP

—CO—

(C 1 -C 12 )alkyl

—CO—

(AA) p

—

—

 —.

16. The conjugate of claim 10 , wherein the linker is selected from one of the following structures:

wherein:

each f is independently 0 or an integer from 1 to 12;

each n is independently 0 or an integer from 1 to 30;

each y is independently 0 or an integer from 1 to 20;

each h is independently 0 or an integer from 1 to 12;

each p is independently 0 or an integer from 1 to 20;

each R is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; and

each R′ is independently selected from hydrogen, a sidechain group of an amino acid, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

17. A pharmaceutical composition comprising:

a conjugate of claim 1 ; and

a pharmaceutically acceptable excipient.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (049221/0673) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; REDWOOD BIOSCIENCE, INC.
Reel/Frame 069751/0100 →
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded May 20, 2019
From: R.P. SCHERER TECHNOLOGIES, LLC; CATALENT PHARMA SOLUTIONS, LLC; REDWOOD BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049221/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2017
From: CHUPRAKOV, STEPAN; KUDIRKA, ROMAS ALVYDAS; MCFARLAND, JESSE M.; GARAFALO, ALBERT W.; RABUKA, DAVID
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 042129/0574 →
Continuity (2)
Provisional Application 62310497 · Mar 18, 2016
Related Publication 20170266302A1 · Sep 21, 2017